Креативная хирургия и онкология (Dec 2020)

Efficacy of Angio-Seal Device for Primary And Complicated Haemostasis: a Multicentre Retrospective Assay

  • I. N. Sorokin,
  • E. B. Shakhov,
  • V. S. Zakharov,
  • D. A. Savenkov,
  • S. A. Ayvazyan,
  • A. A. Frolov

DOI
https://doi.org/10.24060/2076-3093-2020-10-4-259-263
Journal volume & issue
Vol. 10, no. 4
pp. 259 – 263

Abstract

Read online

Background. Femoral approach in endovascular surgery remains relevant being, however, associated with the risk of fatal and non­fatal complications. Modern techniques for instrumental haemostasis achieved with the Angio­Seal device (Terumo Corporation, Japan) provide an opportunity to reduce the number of fatal and non­fatal complications. Aim. A multicentre assay of the efficacy and safety of instrumental puncture closure using Angio­Seal devices (Terumo Corporation, Japan) in various settings and clinical situations.Materials and methods. A multicentre retrospective analysis of 1088 use cases of the Angio­Seal device (Terumo Corporation, Japan) for “primary” and “complicated” instrumental haemostasis after femoral access has been conducted for the years 2018–2020. The mean patient age was 62.3 ± 11.6 years, including 845 men (78.0%) and 243 women (22.0%). Five centres for routine and emergency endovascular radiology participated in the study.Results. The Angio­Seal device (Terumo Corporation, Japan) demonstrated a high method efficiency, with a 97.0% success rate of “primary” instrumental haemostasis (1055 of 1088 total successful haemostatic procedures) in various clinical settings. Arterial thrombosis at the approach side had a 3.0% complication rate (5 of 33 observations), all other complication types associated with haemorrhagic events (8 cases) or device malfunction and damage (20 cases).Discussion. The assay conducted suggests that the incidence of “complicated” instrumental haemostasis relates to technical drawbacks of the device application that required advance planning. The key identified prerequisites for a successful Angio­Seal application (Terumo Corporation, Japan) are the alignment of anchor tube­delivery through soft tissue into the vessel lumen and its positioning inside the vessel.Conclusion. The constructive features and instrumental haemostatic technique realised in the Angio­Seal device (Terumo Corporation, Japan) enable an effective and safe primary sealing of arterial puncture site in 97% cases.

Keywords